As of 4:00pm ET
| -0.28 / -0.57%|
The 5 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.00, with a high estimate of 60.00 and a low estimate of 53.00. The median estimate represents a +16.33% increase from the last price of 49.00.
The current consensus among 6 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.